Projects per year
Abstract
Osteocytes comprising over 90% of the bone cell population are highly susceptible to the adverse effects of glucocorticoids (GC) administration. Here we observed that Dexamethasone (Dex) induces a robust cytoskeleton rearrangement and decreases Cx43 protein expression in osteocyte-like MLO-Y4 cells. Using a Dmp1Cre-mT/mG osteocyte ex vivo culture system, we found significant shortening of dendritic processes in primary osteocytes following Dex administration. Loss of dendritic processes is a consequence of reduced Cx43 connectivity upon Dex induced autophagy in both RFP-GFP-LC3B transfected MLO-Y4 cells and primary calvarial osteocytes from LC3GFP transgenic mice. Upon the induction of autophagy by Dex, Cx43 was internalized into autophagosome/autolysosomes and degraded by autophagy. The degradation was attenuated following lysosomal inhibition using chloroquine (CLQ) and suppression of autophagy by Atg5 silencing. Inhibition Akt-mTORC1 signaling by Dex induces autophagy subsequently resulting in Cx43 degradation. Activation of Akt phosphorylation by IGF-1 attenuated Dex induced autophagy and degradation of Cx43. Together, we demonstrated that GC impair osteocyte cell-cell connectivity via autophagy mediated degradation of Cx43 through inhibition of the Akt-mTORC1 signaling. This may account for the deleterious effect of GC-induced bone loss.
Original language | English |
---|---|
Pages (from-to) | 26966-26978 |
Number of pages | 13 |
Journal | Oncotarget |
Volume | 7 |
Issue number | 19 |
Early online date | 27 Apr 2016 |
DOIs | |
Publication status | Published - 10 May 2016 |
Fingerprint
Dive into the research topics of 'Glucocorticoid impairs cell-cell communication by autophagymediated degradation of connexin 43 in osteocytes'. Together they form a unique fingerprint.Projects
- 1 Finished
-
Molecular Characterization of V-ATPase V0 Domain Subunits el and e2 in Osteoclast
Zheng, M. (Investigator 01), Pavlos, N. (Investigator 02) & Cheng, T. S. (Investigator 03)
NHMRC National Health and Medical Research Council
1/01/13 → 31/12/16
Project: Research